Understanding a Recent Plasma Cell Leukemia Clinical Trial image

Understanding a Recent Plasma Cell Leukemia Clinical Trial

Feb 27, 2024
05:00PM - 06:00PM EST
Online Event
Overview

Dr. Douglas Sborov, Director at the Huntsman Cancer Institute Hematology Disease Center, joins the PCL group to share updates and deeper understanding into one of his recently published clinical trials, Plasma Cell Leukemia: A Multicenter Retrospective Study of 130 Patients. Come with your questions!

Agenda
5:00 PM
Introductions
Audrey Burton-Bethke

Audrey introduces the agenda of the event and our featured speaker Dr. Sborov.

5:05 PM
Presentation
Douglas Sborov, MD

Dr. Sborov talks about his new study.

5:35 PM
Questions and Answers
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators
Healthtree contact Audrey Burton-Bethke

Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.
Healthtree contact Douglas Sborov, MD

Douglas Sborov, MD

Dr. Douglas Sborov is an Assistant Professor in the Division of Hematology and Hematologic Malignancies, Department of Internal Medicine at the University of Utah School of Medicine. He was born and raised in Minnesota, completed his undergraduate education with a Bachelor of Science at the University of Wisconsin-Madison, later completed medical school through the American University of the Caribbean, and spent 3 years in Salt Lake City for his internal medicine residency. After almost 5 years in Columbus, OH, completing hematology, oncology, and bone marrow transplantation fellowships and joining the Division of Hematology as a Clinical Instructor, he and his family were drawn back to the beauty of the Wasatch Front where he joined the Division of Hematology to continue his career as a clinical trialist focused on the treatment of patients with hematologic malignancies. Dr. Sborov is the Director of the Multiple Myeloma Program, an Associate Member of the Huntsman Cancer Institute Experimental Therapeutics Program, Physician Leader of the Multiple Myeloma/Bone Marrow Transplant arm of the HCI Clinical Trials Office (CTO), and an active member of the HCI Protocol Review and Monitoring Committee.